Paclitaxel (P) in combination with carboplatin (C) in the treatment of SCLC patients (a phase II study)

Zarogoulidis, Konstantinos; Kontakiotis, T.; Hatziapostolou, P; Tsianga, E; Papakosta, Paraskevi; Goutsikas, J; Patakas, D.

doi:10.1016/s0169-5002(00)80171-3

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Paclitaxel (P) in combination with carboplatin (C) in the treatment of SCLC patients (a phase II study)

Cited by 2 publications

References 0 publications

Small Cell Lung Cancer

Small Cell Lung Cancer

Phase II Trial of Paclitaxel and Carboplatin in Metastatic Small-Cell Lung Cancer: A Groupe Français de Pneumo-Cancérologie Study

Contact Info

Product

Resources

About